
FOXO4-DRI
Also known as Proxofim, FOXO4 D-Retro-Inverso peptide
Price range: €140 through €285
Discussed for: Clearing aged senescent cells.
Sequence: not listed. Modified or non-standard residues are left out on purpose.
Editorial 1 to 10 estimates from published research, not measured values. How to read these
01 / Identity
What it is
FOXO4-DRI is a synthetic modified peptide. Main reported uses: clearing aged senescent cells. Current status: not approved.
- Molecule type
- Synthetic modified peptide
- How it is taken
- Injection (SC)
- Other names
- Proxofim, FOXO4 D-Retro-Inverso peptide
Route only. This library does not publish doses or protocols.
02 / Mechanism
How it is thought to work
Disrupts FOXO4-p53 binding so senescent cells self-destruct
Mechanisms seen in cells or animals do not always happen the same way in people.
03 / Potential benefits
What people use it for
Clearing aged senescent cells
Animal or no human data
No meaningful human data. Effects and safety in people are unknown, which is not the same as safe.
Listed uses are what people use it for, not proven outcomes.
04 / Known risks
Side effects and risks
Unknown in humans; could affect healthy cells; expensive and often counterfeit
Risk level 5 of 10
Moderate risk score: real side effects are known, and long-term safety is not settled.
Unknown long-term effects count as a risk, not as a clean record.
05 / Regulatory
Regulatory status
- Status
- Not approved
- Details
- Not approved
- Sport (WADA)
- Yes: S0 (unapproved substance)
Status reflects information up to mid-2026 and changes over time. Check current sources.
06 / Evidence quality
How good is the evidence?
07 / Notes and sources
Notes and sources
- Animal only means effects and safety in humans are unknown, not that they are proven safe.
- Products sold online as research peptides are unregulated. Tests of such products often find wrong amounts, impurities or a different compound.
- Anyone using compounds like this regularly should have medical supervision and bloodwork (for example IGF-1, glucose and HbA1c, hormones, lipids).
- Source: Peptide Reference Table, an editorial review of published research up to mid-2026. Scores are 1 to 10 editorial estimates, not measured values. Regulatory and WADA status change over time.
Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound.
Your history